Precirix’s Series B Establishes Champion in Radiopharmaceuticals

Big European venture capital firms Jeito, Forbion, and Inkef Capital have teamed up to propel the local radiopharmaceutical scene by investing €80M in the Belgian firm Precirix.

Europe has a long history of expertise in the development of radiopharmaceutical drugs. One of the pioneers…

Source: www.labiotech.eu – Read more